×
Did you mean: A M Pharma
We are a dedicated team driven to bring treatment options to severely ill patients, their families and health care professionals. Learn more ...
People also ask
AM-Pharma is a clinical stage biopharmaceutical company based in Utrecht, the Netherlands. AM-Pharma, founded in 2001 and based in Utrecht, the Netherlands, is ...
Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury. Sector. Healthcare. Country. Netherlands.
AM–Pharma develops novel recombinant human alkaline phosphatase (AP) therapeutics, which have the potential to be “first-in-class” medicines and transform the ...
Sep 26, 2023 · AM-Pharma cuts staff, says goodbye to CEO as lead kidney injury asset redirected ... After failing in a phase 3 study for a severe kidney ...
AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.
A M Farma from pitchbook.com
Operator of a medical research firm intended to develop alkaline phosphatase biologic therapies to treat acute kidney injury. The company develops an enzyme ...
Aug 1, 2021 · AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use. Website: http://www.am-pharma.com.
AM-Pharma is a biopharmaceutical company that focuses on developing treatments for severe medical conditions. Use the CB Insights Platform to explore ...
A M Farma from biotech-spain.com
Sep 27, 2023 · AM-Pharma B.V. today announced an updated clinical development strategy to evaluate ilofotase alfa in two indications. The company's proprietary ...